Validity of enriched enrollment, randomized withdrawal trials

Affiliations

Comment

Xiulu Ruan et al. Pain. 2016 Jan.

. 2016 Jan;157(1):280.

doi: 10.1097/j.pain.0000000000000347.

¹ Department of Anesthesiology, Louisiana State University Health Science Center, New Orleans, LA, USA.

No abstract available

Comment on

Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting.
Moore RA, Wiffen PJ, Eccleston C, Derry S, Baron R, Bell RF, Furlan AD, Gilron I, Haroutounian S, Katz NP, Lipman AG, Morley S, Peloso PM, Quessy SN, Seers K, Strassels SA, Straube S. Moore RA, et al. Pain. 2015 Aug;156(8):1382-1395. doi: 10.1097/j.pain.0000000000000088. Pain. 2015. PMID: 25985142

1. Furlan AD, Chaparro LE, Irvin E, Mailis-Gagnon A. A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain. Pain Res Manag 2011;16:337.
1. Jones DS, Podolsky SH. The history and fate of the gold standard. Lancet 2015;385:1502–3.
1. Moore RA, Wiffen PJ, Eccleston C, Derry S, Baron R, Bell RF, Furlan AD, Gilron I, Haroutounian S, Katz NP. Systematic review of enriched-enrolment randomised-withdrawal trial designs in chronic pain: a new framework for design and reporting. PAIN 2015;156:1382–95.
1. Schork NJ. Personalized medicine: time for one-person trials. Nature 2015;520:609–11.